The Corona Cabinet on Wednesday approved the enlarging of the maximum occupancy allowed in street stores, as the infection numbers in the country remained stable.
The number of customers now allowed in a store is one person for every seven square meters of space in the store up to a maximum of 10 people in the store, an increase from the four previously approved.
Professor Eran Segal, a scientist at the Weizmann Institute who has been posting daily data and analysis on Coronavirus (COVID-19) in Israel, noted this week on Tuesday that 16 days after stage 2 in the easing of the Corona restrictions commenced, there is no significant increase in morbidity
The number of new Corona inpatients remained stable, and the number of new verified cases increased slightly, but so did the number of tests.
The Arab sector continues to increase its percentage in the new verified cases, 45% of the cases compared to its share in the population of 20%.
Only 5% of all patients are from the ultra-Orthodox sector, which was previously a source of many new cases.
The Ministry of Health updated Thursday that it recorded 780 new COVID-19 cases in the past 24 hours.
Of the 46,385 tests done Wednesday, a low 1.7% returned positive.
According to the data, 304 corona patients are hospitalized in serious condition, of whom 138 are on life support.
In the meantime, Prime Minister Benjamin Netanyahu on Wednesday evening announced “good news on the coronavirus front: The day before yesterday I spoke with Moderna CEO Stephane Bancel, and yesterday I spoke with Moderna Chief Medical Officer Tal Zaks, about signing to increase the number of doses that will be allocated to the citizens of Israel. I believe that we are on the verge of signing. This is excellent news.”
The Moderna biotechnology company announced that its Coronavirus vaccine has an efficacy of 94.5%.
The NIH-appointed Data Safety Monitoring Board (DSMB) for its Phase 3 study of mRNA-1273, its vaccine candidate against COVID-19, has informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
Israel will be among the first countries to receive Moderna’s vaccine.
Netanyahu added that Pfizer, with which Israel signed last week for eight million doses, is going to apply for approval with the US medical authorities in a few days, to supply these vaccines.
“We will be among the first to receive them. This is the beginning of the end of the coronavirus,” he declared.
Of the 326,628 Israelis who have contracted the virus since the outbreak in the country in February, 2,739 have died.